All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Evaluation of the leishmanicidal activity of rutaceae and lauraceae ethanol extracts on golden Syrian hamster (Mesocricetus auratus) peritoneal macrophages

Author(s): N. A. Chavez Enciso1, E. D. Coy-barrera2, O. J. Patino3, L E. Cuca3, Gabriela Delgado1
1Immunotoxicology Research Group, Pharmacy Department, Universidad Nacional de Colombia. Bogota, Colombia 2Universidad Militar, Nueva Granada 3Natural Plant Products Group, Chemistry Department, Universidad Nacional de Colombia. Bgota-Colombia

Correspondence Address:
Gabriela Delgado Immunotoxicology Research Group, Pharmacy Department, Universidad Nacional de Colombia. Bogota Colombia E-mail: [email protected]


Traditional medicine has provided a number of therapeutic solutions for the control of infectious agents, cancers, and other diseases. After screening a wide variety of Colombian plant extracts, we have identified promising antileishmanial activity in ethanol extracts from Ocotea macrophylla (Lauraceae) and Zanthoxyllum monophyllum (Rutaceae). In this study, we evaluated the in vitro activity of two ethanol extracts, one from Ocotea macrophylla and the other from Zanthoxyllum monophyllum and one alkaloid fraction of ethanol extract of Zanthoxyllum monophyllum, on peritoneal macrophages isolated from golden Syrian hamsters (Mesocricetus auratus) infected with Leishmania panamensis and Leishmania major promastigotes. All of the extracts studied displayed promising (≤2) selectivity indices (S/I), the most significant of which were for ethanol extract of Zanthoxyllum monophyllum against Leishmania panamensis (S/I=12) and alkaloid fraction of ethanol extract of Zanthoxyllum monophyllum against Leishmania major (S/I=11). These results support the use of ethanol extracts and alkaloid fractions isolated from Ocotea macrophylla and Zanthoxyllum monophyllum, respectively; as therapeutic options for cutaneous leishmaniasis.



Share this